Insulet Corp. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Insulet Corp. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Insulet Corp. do? Business model and key facts
Get the full picture of Insulet Corp.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Devices
Employees (FY): 5400
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Stocks related to Insulet Corp.
Selected based on industry alignment and relative market positioning.
Events and news impacting Insulet Corp. stock
Earnings, coporate decisions and industry developments that can affect the share price.
Insulet Corp. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
